Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Prerna Malaney"'
Autor:
Pedro Aguilar Garrido, Maria Velasco Estevez, Miguel Ángel Navarro Aguadero, María Hernández Sánchez, Prerna Malaney, Marisa Hornbaker, Xiaorui Zhang, Marta Ibañez Navarro, Alejandra Ortiz-Ruiz, Álvaro Otero-Sobrino, Diego Megías, Manuel Pérez, Jesús Gómez, Gadea Mata, Orlando Dominguez, Osvaldo Grana, Eduardo Caleiras, Marta Isasa, Paloma Jimena de Andrés, Sandra Rodriguez, Raúl Torres, Oleksandra Sirozh, Vanesa Lafarga, Joaquín Martínez-Lopez, Sean Post, Miguel Gallardo
Publikováno v:
HemaSphere, Vol 7, p e8819188 (2023)
Externí odkaz:
https://doaj.org/article/31825dcb3d8a4b67a90a4ac36218cf8e
Autor:
Sean M. Post, Huaxian Ma, Prerna Malaney, Xiaorui Zhang, Marisa J.L. Aitken, Po Yee Mak, Vivian R. Ruvolo, Tomoko Yasuhiro, Ryohei Kozaki, Lauren E. Chan, Lauren B. Ostermann, Marina Konopleva, Bing Z. Carter, Courtney DiNardo, Michael D. Andreeff, Joseph D. Khoury, Peter P. Ruvolo
Publikováno v:
Haematologica, Vol 107, Iss 6 (2021)
FMS-like Tyrosine Kinase 3 (FLT3) mutation is associated with poor survival in acute myeloid leukemia (AML). The specific Anexelekto/MER Tyrosine Kinase (AXL) inhibitor, ONO-7475, kills FLT3-mutant AML cells with targets including Extracellular- sign
Externí odkaz:
https://doaj.org/article/48b85cbe0a1047eaba094b35a51665e8
Autor:
Prerna Malaney, María Velasco-Estevez, Pedro Aguilar-Garrido, Marisa J. L. Aitken, Lauren E. Chan, Xiaorui Zhang, Sean M. Post, Miguel Gallardo
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
B-cell lymphomas are one of the most biologically and molecularly heterogeneous group of malignancies. The inherent complexity of this cancer subtype necessitates the development of appropriate animal model systems to characterize the disease with th
Externí odkaz:
https://doaj.org/article/e1ec8fbf3f81483b8c448576d353cc89
Autor:
Jennifer H. Kong, Claudia G. Vasquez, Sweta Agrawal, Prerna Malaney, Maria M. Mikedis, Andrea B. Moffitt, Lexy von Diezmann, Christina M. Termini
Publikováno v:
Trends in Biochemical Sciences. 48:203-210
The process of evaluating and negotiating a tenure-track job offer is unstructured and highly variable, making it susceptible to bias and inequitable outcomes. We outline common aspects of and recommendations for negotiating an academic job offer in
Autor:
Pedro Aguilar-Garrido, María Velasco-Estévez, Miguel Ángel Navarro-Aguadero, María Hernandez-Sanchez, Prerna Malaney, Xiaroui Zhang, Marisa J. L. Aitken, Alvaro Otero-Sobrino, Marta Ibañez-Navarro, Alejandra Ortiz-Ruiz, Diego Megias, Manuel Pérez-Martínez, Gadea Mata, Jesús Gomez, Orlando Dominguez, Osvaldo Graña-Castro, Eduardo Caleiras, Paloma Jimena de Andres, Sandra Rodriguez, Raúl Torres, Oleksandra Sirozh, Vanesa Lafarga, Joaquín Martinez-Lopez, Sean M. Post, Miguel Gallardo
The nucleolus is a dynamic structure where ribosome subunits are produced. Indeed, nucleoli respond to any change in cellular homeostasis by altering the rate of ribosome biogenesis, thus working as a stress sensor. Therefore, an imbalance in ribosom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5197402493775104cec9ed910821d935
https://doi.org/10.1101/2023.03.07.531270
https://doi.org/10.1101/2023.03.07.531270
Autor:
Dhwani N. Rupani, Fredrik I. Thege, Vidhi Chandra, Hajar Rajaei, Robert W. Cowan, Sonja M. Wörmann, Olivereen Le Roux, Prerna Malaney, Sara L. Manning, Jack Hashem, Jennifer Bailey-Lundberg, Andrew D. Rhim, Florencia McAllister
Publikováno v:
Development. 150
Adenosine deaminase acting on RNA 1 (ADAR1) is an RNA-binding protein that deaminates adenosine (A) to inosine (I). A-to-I editing alters post-transcriptional RNA processing, making ADAR1 a crucial regulator of gene expression. Consequently, Adar1 ha
Autor:
Joseph D. Khoury, Prerna Malaney, Courtney D. DiNardo, Bing Z. Carter, Lauren B Ostermann, Michael Andreeff, Ryohei Kozaki, Xiaorui Zhang, Marina Konopleva, Sean M. Post, Marisa J.L. Aitken, Peter P. Ruvolo, Huaxian Ma, Vivian Ruvolo, Tomoko Yasuhiro, Po Yee Mak, Lauren E. Chan
Publikováno v:
Haematologica. 107:1311-1322
FMS-like Tyrosine Kinase 3 (FLT3) mutation is associated with poor survival in acute myeloid leukemia (AML). The specific Anexelekto/MER Tyrosine Kinase (AXL) inhibitor, ONO-7475, kills FLT3-mutant AML cells with targets including Extracellular- sign
Autor:
Marisa J L Aitken, Prerna Malaney, Xiaorui Zhang, Shelley M Herbrich, Lauren Chan, Oscar Benitez, Ashley G Rodriguez, Huaxian Ma, Rodrigo Jacamo, Ruizhi Duan, Todd M Link, Steven M Kornblau, Rashmi Kanagal-Shamanna, Carlos E Bueso-Ramos, Sean M Post
Publikováno v:
NAR Cancer. 4
Acute myeloid leukemia (AML) is driven by numerous molecular events that contribute to disease progression. Herein, we identify hnRNP K overexpression as a recurrent abnormality in AML that negatively correlates with patient survival. Overexpression
Publikováno v:
Methods (San Diego, Calif.). 208
RNA-binding proteins (RBPs) typically bind to RNA in a sequence-specific manner, resulting in post-transcriptional gene regulation. While the various classes of RNA-binding domains are largely structured, flexible linkers are frequently observed betw
Autor:
Sean M. Post, Lauren E. Chan, Xiaorui Zhang, Oscar Benitez, Kerstin Rahn, Todd Link, Clifford Stephan, Eun Cho, Kevin Dalby, Prerna Malaney
Publikováno v:
Blood. 140:4951-4952